• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮性卵巢癌中AEG-1表达分析:揭示高级别与低级别浆液性癌之间的差异

AEG-1 expression analysis in epithelial ovarian carcinoma: Uncovering distinctions between high-grade and low-grade serous carcinoma.

作者信息

Irawan Budi, Tjokroprawiro Brahmana Askandar, Saraswati Wita, Yuliati Indra, Mulawardhana Pungky, Utomo Budi, Ariani Grace

机构信息

Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Academic Hospital, Surabaya, East Java 60286, Indonesia.

Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Airlangga, Airlangga University Academic Hospital, Surabaya, East Java 60115, Indonesia.

出版信息

Mol Clin Oncol. 2025 Jun 4;23(2):70. doi: 10.3892/mco.2025.2865. eCollection 2025 Aug.

DOI:10.3892/mco.2025.2865
PMID:40529100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12172611/
Abstract

Epithelial ovarian carcinoma (EOC) is the most common form of ovarian cancer and is associated with a poor prognosis. Astrocyte Elevated Gene-1 (AEG-1) is an oncogene implicated in cancer cell growth and progression. The present study examined AEG-1 expression in EOC, specifically comparing high-grade serous ovarian carcinoma (HGSOC) and low-grade serous ovarian carcinoma (LGSOC). The present retrospective analytical study employed a cross-sectional design and included women diagnosed with HGSOC or LGSOC between January 2021 and December 2023. Extracted data included demographic, laboratory and clinicopathological characteristics. In addition to comparing AEG-1 expression in HGSOC and LGSOC, associations between these histological subtypes and the extracted variables, as well as associations between AEG-1 expression and these variables, were assessed. Of the 74 patients initially identified, 24 were excluded, resulting in a final sample of 50 patients 23 with LGSOC and 27 with HGSOC. A statistically significant association was found between residual disease and cancer histopathology [odds ratio: 7.219; 95% confidence interval (CI): 1.399-37.252; P=0.024), whereas no significant associations were observed with other variables. AEG-1 expression was significantly higher in HGSOC compared with LGSOC (relative risk: 3.228; 95% CI: 1.188-8.776; P=0.012), with high AEG-1 expression observed more frequently in HGSOC (65.7%) than in LGSOC (34.3%). In conclusion, AEG-1 expression was significantly elevated in HGSOC compared with LGSOC, suggesting a potential role for AEG-1 in the progression of HGSOC.

摘要

上皮性卵巢癌(EOC)是卵巢癌最常见的形式,且预后较差。星形胶质细胞上调基因1(AEG-1)是一种与癌细胞生长和进展相关的癌基因。本研究检测了EOC中AEG-1的表达,特别比较了高级别浆液性卵巢癌(HGSOC)和低级别浆液性卵巢癌(LGSOC)。本回顾性分析研究采用横断面设计,纳入了2021年1月至2023年12月期间被诊断为HGSOC或LGSOC的女性。提取的数据包括人口统计学、实验室和临床病理特征。除了比较HGSOC和LGSOC中AEG-1的表达外,还评估了这些组织学亚型与提取变量之间的关联,以及AEG-1表达与这些变量之间的关联。在最初确定的74例患者中,排除了24例,最终样本为50例患者,其中23例为LGSOC,27例为HGSOC。发现残留病灶与癌症组织病理学之间存在统计学显著关联[比值比:7.219;95%置信区间(CI):1.399 - 37.252;P = 0.024],而与其他变量未观察到显著关联。与LGSOC相比,HGSOC中AEG-1表达显著更高(相对风险:3.228;95% CI:1.188 - 8.776;P = 0.012),HGSOC中高AEG-1表达的发生率(65.7%)高于LGSOC(34.3%)。总之,与LGSOC相比,HGSOC中AEG-1表达显著升高,提示AEG-1在HGSOC进展中可能发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bdb/12172611/87cd531b513d/mco-23-02-02865-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bdb/12172611/fa827174cd5a/mco-23-02-02865-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bdb/12172611/87cd531b513d/mco-23-02-02865-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bdb/12172611/fa827174cd5a/mco-23-02-02865-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bdb/12172611/87cd531b513d/mco-23-02-02865-g01.jpg

相似文献

1
AEG-1 expression analysis in epithelial ovarian carcinoma: Uncovering distinctions between high-grade and low-grade serous carcinoma.上皮性卵巢癌中AEG-1表达分析:揭示高级别与低级别浆液性癌之间的差异
Mol Clin Oncol. 2025 Jun 4;23(2):70. doi: 10.3892/mco.2025.2865. eCollection 2025 Aug.
2
Prognostic factors for return to work in breast cancer survivors.乳腺癌幸存者恢复工作的预后因素。
Cochrane Database Syst Rev. 2025 May 7;5(5):CD015124. doi: 10.1002/14651858.CD015124.pub2.
3
Tumor-infiltrating lymphocytes are the key determinants of pathological features associated with pathogenic variants in high-grade serous ovarian carcinoma.肿瘤浸润淋巴细胞是与高级别浆液性卵巢癌致病变异相关的病理特征的关键决定因素。
Front Med (Lausanne). 2025 Jun 3;12:1555883. doi: 10.3389/fmed.2025.1555883. eCollection 2025.
4
Interventions for central serous chorioretinopathy: a network meta-analysis.中心性浆液性脉络膜视网膜病变的干预措施:一项网状Meta分析
Cochrane Database Syst Rev. 2025 Jun 16;6(6):CD011841. doi: 10.1002/14651858.CD011841.pub3.
5
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.
6
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.KRAS rs61764370 在浸润性上皮性卵巢癌中的作用:对临床检测的影响。
Clin Cancer Res. 2011 Jun 1;17(11):3742-50. doi: 10.1158/1078-0432.CCR-10-3405. Epub 2011 Mar 8.
7
Electronic cigarettes for smoking cessation.用于戒烟的电子烟。
Cochrane Database Syst Rev. 2025 Jan 29;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub9.
8
Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.孕激素产前给药预防多胎妊娠妇女自发性早产。
Cochrane Database Syst Rev. 2019 Nov 20;2019(11):CD012024. doi: 10.1002/14651858.CD012024.pub3.
9
Pelvic floor muscle training with feedback or biofeedback for urinary incontinence in women.针对女性尿失禁的盆底肌训练及反馈或生物反馈训练
Cochrane Database Syst Rev. 2025 Mar 11;3(3):CD009252. doi: 10.1002/14651858.CD009252.pub2.
10
St Andrews Referral Delay in Skin Cancer (StARDISC): a study of keratinocyte skin cancer time to treatment, growth, invasiveness, British Association of Dermatologists risk factors and excision adequacy.圣安德鲁斯皮肤癌转诊延迟研究(StARDISC):一项关于角质形成细胞皮肤癌治疗时间、生长、侵袭性、英国皮肤科医师协会危险因素及切除充分性的研究。
Br J Dermatol. 2025 Jun 20;193(1):157-166. doi: 10.1093/bjd/ljaf097.

本文引用的文献

1
mRNA-seq-based analysis predicts: AEG-1 is a therapeutic target and immunotherapy biomarker for pan-cancer, including OSCC.基于 mRNA-seq 的分析预测:AEG-1 是一种治疗靶点和免疫治疗生物标志物,适用于多种癌症,包括口腔鳞状细胞癌。
Front Immunol. 2024 Oct 17;15:1484226. doi: 10.3389/fimmu.2024.1484226. eCollection 2024.
2
The survival benefit associated with complete macroscopic resection in epithelial ovarian cancer is histotype specific.上皮性卵巢癌中完全肉眼切除与生存获益相关,具有组织学类型特异性。
JNCI Cancer Spectr. 2024 Jul 1;8(4). doi: 10.1093/jncics/pkae049.
3
Progesterone Enhances Niraparib Efficacy in Ovarian Cancer by Promoting Palmitoleic-Acid-Mediated Ferroptosis.
孕酮通过促进棕榈油酸介导的铁死亡增强尼拉帕利在卵巢癌中的疗效。
Research (Wash D C). 2024 May 24;7:0371. doi: 10.34133/research.0371. eCollection 2024.
4
Advances in precision therapy of low-grade serous ovarian cancer: A review.低级别浆液性卵巢癌精准治疗的进展:综述。
Medicine (Baltimore). 2024 Apr 26;103(17):e34306. doi: 10.1097/MD.0000000000034306.
5
Global epidemiology of epithelial ovarian cancer.上皮性卵巢癌的全球流行病学。
Nat Rev Clin Oncol. 2024 May;21(5):389-400. doi: 10.1038/s41571-024-00881-3. Epub 2024 Mar 28.
6
High-Grade Serous Ovarian Cancer-A Risk Factor Puzzle and Screening Fugitive.高级别浆液性卵巢癌——一个危险因素谜团与筛查难题
Biomedicines. 2024 Jan 19;12(1):229. doi: 10.3390/biomedicines12010229.
7
Biology-driven therapy advances in high-grade serous ovarian cancer.基于生物学的治疗方法在高级别浆液性卵巢癌中的进展。
J Clin Invest. 2024 Jan 2;134(1):e174013. doi: 10.1172/JCI174013.
8
Prognostic Factors Influencing Survival in Ovarian Cancer Patients: A 10-Year Retrospective Study.影响卵巢癌患者生存的预后因素:一项10年回顾性研究
Cancers (Basel). 2023 Dec 5;15(24):5710. doi: 10.3390/cancers15245710.
9
A single-cell landscape of pre- and post-menopausal high-grade serous ovarian cancer ascites.绝经前和绝经后高级别浆液性卵巢癌腹水的单细胞图谱。
iScience. 2023 Aug 25;26(10):107712. doi: 10.1016/j.isci.2023.107712. eCollection 2023 Oct 20.
10
Low-grade serous ovarian cancer: expert consensus report on the state of the science.低级别浆液性卵巢癌:科学现状的专家共识报告。
Int J Gynecol Cancer. 2023 Sep 4;33(9):1331-1344. doi: 10.1136/ijgc-2023-004610.